Researchers evaluated associations of breast cancer incidence with different dietary phosphate levels.
Bristol Myers Squibb agrees to acquire RayzeBio for $4.1bn
Share this article The boards of directors of both BMS and RayzeBio have granted unanimous approval for the merger. Credit: JHVEPhoto / Shutterstock.com. Bristol Myers